795 reports of this reaction
1.6% of all DESOGESTREL AND ETHINYL ESTRADIOL reports
#17 most reported adverse reaction
STOMATITIS is the #17 most commonly reported adverse reaction for DESOGESTREL AND ETHINYL ESTRADIOL, manufactured by Teva Pharmaceuticals USA, Inc.. There are 795 FDA adverse event reports linking DESOGESTREL AND ETHINYL ESTRADIOL to STOMATITIS. This represents approximately 1.6% of all 50,755 adverse event reports for this drug.
Patients taking DESOGESTREL AND ETHINYL ESTRADIOL who experience stomatitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
STOMATITIS is a less commonly reported adverse event for DESOGESTREL AND ETHINYL ESTRADIOL, but still significant enough to appear in the safety profile.
In addition to stomatitis, the following adverse reactions have been reported for DESOGESTREL AND ETHINYL ESTRADIOL:
The following drugs have also been linked to stomatitis in FDA adverse event reports:
STOMATITIS has been reported as an adverse event in 795 FDA reports for DESOGESTREL AND ETHINYL ESTRADIOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
STOMATITIS accounts for approximately 1.6% of all adverse event reports for DESOGESTREL AND ETHINYL ESTRADIOL, making it a notable side effect.
If you experience stomatitis while taking DESOGESTREL AND ETHINYL ESTRADIOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.